PRPO
Precipio, Inc.24.02
-0.04-0.17%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
42.08MP/E (TTM)
-Basic EPS (TTM)
-0.81Dividend Yield
0%Recent Filings
8-K
2025 revenues up 30%
Precipio announced preliminary 2025 results on February 25, 2026: revenues hit $24.0M, up 30% from $18.5M in 2024, with Q4 at $6.7M (23% YoY growth). Adjusted EBITDA swung to $0.95M in Q4 and $1.23M full-year, versus $0.40M and ($1.5M) prior year. Cash from operations turned positive at $368K in Q4. Business now eyes long-term growth.
8-K
Exec comp boosted, options tied to $40 stock
Precipio's Compensation Committee approved executive salary hikes effective January 1, 2026—Ilan Danieli to $350,000, Zaki Sabet and Ayman Mohamed to $300,000 each—plus 2026 bonuses up to $200,000 and 70,000 performance options vesting only if stock hits $40 VWAP over 10 days. Adjustments reward restructuring gains and pathology improvements while tying pay to shareholder value. Retention trumps all.
10-Q
Q3 FY2025 results
Precipio's Q3 revenue hit $6.8M, up 30% y/y from $5.2M, driven by 19% more diagnostic cases; gross margin held steady at 44%. Operating loss narrowed to $61K from $597K y/y, but net loss widened slightly to $79K versus $626K due to minor interest costs. Cash climbed to $2.3M with $0.3M YTD operating cash flow (derived) and $1.3M warrant proceeds; debt fell to $85K. Leases bulked up the balance sheet. Warrants delivered cash.
8-K
Terminates ATM agreement
Precipio terminated its at-the-market sales agreement with A.G.P., effective September 2, 2025, after selling 11,847 shares for $0.1 million net proceeds since April 2023. No further stock offerings possible under it. CEO cites operational cash flow positivity and cash growth as reasons. Management prioritizes shareholder value.
IPO
Website
Employees
Sector
Industry
BIAF
bioAffinity Technologies, Inc.
1.38-0.10
CDIO
Cardio Diagnostics Holdings Inc
3.10+0.02
CHEK
Check-Cap Ltd.
1.61+0.03
DTIL
Precision BioSciences, Inc.
4.82+0.02
EXAS
Exact Sciences Corporation
101.76+0.02
IDXG
Interpace Biosciences, Inc.
1.14-0.02
ILMN
Illumina, Inc.
131.56-3.36
ISPC
iSpecimen Inc.
0.41-0.01
NEO
NeoGenomics, Inc.
11.67-0.25
TTOO
T2 Biosystems, Inc.
0.01+0.00